Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma.
Cattaneo G, Ventin M, Arya S, Kontos F, Michelakos T, Sekigami Y, Cai L, Villani V, Sabbatino F, Chen F, Sadagopan A, Deshpande V, Moore PA, Ting DT, Bardeesy N, Wang X, Ferrone S, Ferrone CR. Cattaneo G, et al. Among authors: sekigami y. Cancer Lett. 2024 Apr 10;587:216713. doi: 10.1016/j.canlet.2024.216713. Epub 2024 Feb 14. Cancer Lett. 2024. PMID: 38364961
Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment.
Pulvirenti A, Javed AA, Michelakos T, Sekigami Y, Zheng J, Kalvin HL, McIntyre CA, Nebbia M, Chou JF, Gonen M, Raj N, Reidy-Lagunes DL, Zureikat AH, Ferrone CR, He J, Wei AC; PAncreatic Neuroendocrine Disease Alliance (PANDA). Pulvirenti A, et al. Among authors: sekigami y. Ann Surg. 2023 Nov 1;278(5):e1063-e1067. doi: 10.1097/SLA.0000000000005809. Epub 2023 Jan 24. Ann Surg. 2023. PMID: 37796750
Response to Commentary on '"Long-Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort".
Bolm L, Nebbia M, Wei AC, Zureikat AH, Fernández-Del Castillo C, Zheng J, Pulvirenti A, Javed AA, Sekigami Y, Petruch N, Qadan M, Lillemoe KD, He J, Ferrone CR. Bolm L, et al. Among authors: sekigami y. Ann Surg Open. 2023 Apr 17;4(2):e277. doi: 10.1097/AS9.0000000000000277. eCollection 2023 Jun. Ann Surg Open. 2023. PMID: 37601459 Free PMC article. No abstract available.
Response to Commentary "Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Non-Functional Pancreatic Neuroendocrine Tumors?".
Bolm L, Nebbia M, Wei AC, Zureikat AH, Fernández-Del Castillo C, Zheng J, Pulvirenti A, Javed AA, Sekigami Y, Petruch N, Qadan M, Lillemoe KD, He J, Ferrone CR. Bolm L, et al. Among authors: sekigami y. Ann Surg Open. 2023 Feb 20;4(1):e245. doi: 10.1097/AS9.0000000000000245. eCollection 2023 Mar. Ann Surg Open. 2023. PMID: 37600878 Free PMC article. No abstract available.
Learning Curve of Single-site Robotic Cholecystectomy: A Cumulative Sum Analysis.
Kudsi OY, Kaoukabani G, Friedman A, Sekigami Y, Bou-Ayash N, Bahadir J, Crawford AS, Gokcal F. Kudsi OY, et al. Among authors: sekigami y. Surg Laparosc Endosc Percutan Tech. 2023 Jun 1;33(3):310-316. doi: 10.1097/SLE.0000000000001178. Surg Laparosc Endosc Percutan Tech. 2023. PMID: 37172003
A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter study.
Javed AA, Pulvirenti A, Zheng J, Michelakos T, Sekigami Y, Razi S, McIntyre CA, Thompson E, Klimstra DS, Deshpande V, Singhi AD, Weiss MJ, Wolfgang CL, Cameron JL, Wei AC, Zureikat AH, Ferrone CR, He J; Pancreatic Neuroendocrine Disease Alliance (PANDA). Javed AA, et al. Among authors: sekigami y. Surgery. 2022 Dec;172(6):1800-1806. doi: 10.1016/j.surg.2022.08.022. Epub 2022 Oct 1. Surgery. 2022. PMID: 36192215
32 results